Bogenschutz, Michael P.

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 1,151

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., et al. (2021) · Nature Medicine

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 1,004

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial

Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 711

MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial

Mitchell, J. M., Ot’alora G., M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., et al. (2023) · Nature Medicine

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 455

Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial

Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 361

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 226

Individual experiences in four cancer patients following psilocybin-assisted psychotherapy

Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S. K., Owens, L. T., Bossis, A. P., Belser, A. B., Agin-Liebes, G., Bogenschutz, M. P., & Ross, S. (2018) · Frontiers in Pharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 131

Development of a bibliography on religion, spirituality and addictions

GEPPERT, C., BOGENSCHUTZ, M. P., & MILLER, W. R. (2007) · Drug and Alcohol Review

Religion, Spirituality, and PsychologySubstance Abuse Treatment and Outcomes

Cited by 129

Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial

Bogenschutz, M. P., Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., et al. (2014) · JAMA Internal Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 118

Health status of ayahuasca users

Barbosa, P. C. R., Mizumoto, S., Bogenschutz, M. P., & Strassman, R. J. (2012) · Drug Testing and Analysis

Psychedelics and Drug StudiesAlkaloids: synthesis and pharmacology

Cited by 112

Psychological and neuropsychological assessment of regular hoasca users

Barbosa, P. C. R., Strassman, R. J., da Silveira, D. X., Areco, K., Hoy, R., Pommy, J., Thoma, R., & Bogenschutz, M. (2016) · Comprehensive Psychiatry

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 105

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G, M., Garas, W., Paleos, C., Gorman, I., et al. (2023) · Focus

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 93

Community Reinforcement and Family Training: A pilot comparison of group and self-directed delivery

Manuel, J. K., Austin, J. L., Miller, W. R., McCrady, B. S., Tonigan, J. S., Meyers, R. J., Smith, J. E., & Bogenschutz, M. P. (2012) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesCounseling, Therapy, and Family Dynamics

Cited by 55

Studying the Effects of Classic Hallucinogens in the treatment of alcoholism: Rationale, methodology, and current research with psilocybin

Bogenschutz, M. (2013) · Current Drug Abuse Reviews

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 47

Multidimensional personality changes following psilocybin-assisted therapy in patients with alcohol use disorder: results from a double-blind, placebo-controlled clinical trial

Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P. (2025) · American Journal of Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 31

Gabapentin enacarbil extended-release versus placebo: a likely responder reanalysis of a randomized clinical trial

Laska, E. M., Siegel, C. E., Lin, Z., Bogenschutz, M., & Marmar, C. R. (2020) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 23

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

O'Donnell, K. C., Mennenga, S. E., Owens, L. T., Podrebarac, S. K., Baron, T., Rotrosen, J., Ross, S., Forcehimes, A. A., & Bogenschutz, M. P. (2022) · Contemporary Clinical Trials

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 23